Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Ferrari, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Ferrari, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org

EUROPEAN HEART JOURNAL SUPPLEMENTS

Key lessons from morbidity/mortality trials: evidence for benefits of the perindopril/amlodipine combination ESC MUNICH 2008

Roberto Ferrari1,2

1 Department of Cardiology, Università degli Studi di Ferrara, Italy
2 Cardiovascular Research Center IRCCS, Salvatore Maugeri Foundation, Gussago, Brescia, Italy

The first 10% of the full text of this article appears below.

In the last 50 years, mean life span has increased by almost 8 years. Cardiology has played an important role in this achievement. It has been estimated that the contribution of cardiology to the extension of life accounts for almost 6 years!

This depends in part, of course, on the fact that cardiovascular disease itself contributes to more than 50% of total mortality of population, but also largely on the success of interventional cardiology and cardiovascular therapy.

The contribution of revascularization by any means, but particularly by primary angioplasty, has changed the natural history of acute myocardial infarction (MI) to the extent that, today, the need for intensive care units to treat acute MI is often questioned. Equally, there have been huge advances in heart surgery for revascularization of complex coronary, valvular, and congenital diseases, and . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?